Yonetani Y, Iwaki K, Ishii M, Harada H
Jpn J Pharmacol. 1987 Apr;43(4):399-405. doi: 10.1254/jjp.43.399.
The uric acid-retaining effects of diuretics were studied using sodium-restricted spontaneously hypertensive rats. Test agents were administered orally once a day for two weeks. Diuretic thiazides such as trichlormethiazide and hydrochlorothiazide and loop diuretics such as furosemide and indacrinone clearly reduced the renal function for uric acid excretion in treatment which produced major effects such as diuresis, saluresis and hypotension. However, a new diuretic with uricosuric activity, S-8666, developed in our laboratories, had no effect on the renal handling of uric acid at doses which showed major effects similar to those of other diuretics. The results should aid the understanding of the utility of S-8666 as a new diuretic antihypertensive which does not cause hyperuricemia during therapy.
使用限钠自发性高血压大鼠研究了利尿剂的尿酸潴留作用。测试药物每天口服一次,持续两周。利尿噻嗪类药物如三氯噻嗪和氢氯噻嗪以及袢利尿剂如呋塞米和茚达立酮在产生利尿、利钠和低血压等主要作用的治疗中,明显降低了肾脏排泄尿酸的功能。然而,我们实验室开发的一种具有促尿酸排泄活性的新型利尿剂S - 8666,在显示出与其他利尿剂相似的主要作用的剂量下,对尿酸的肾脏处理没有影响。这些结果应有助于理解S - 8666作为一种新型利尿降压药在治疗期间不会引起高尿酸血症的效用。